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http://dx.doi.org/10.1016/j.jfma.201Two children with shield ulcer in vernal keratoconjunctivitis unresponsive to steroid therapy
received plaque removal by superficial keratectomy, followed by amniotic membrane trans-
plantation (AMT). Hematoxylin and eosin staining of the excised corneal specimen revealed
a thick layer of eosinophilic material attached to the Bowman’s layer. These deposits were
positive for eosinophil granule major basic protein, as confirmed by an immunohistochemical
study. The shield ulcer healed after the amniotic membrane was removed. No recurrent
corneal plaque developed, although corneal opacity complicated in both cases. Lamellar ker-
atectomy with AMT offers an effective management by removing the cytotoxic plaques and
protecting the denuded stroma from deposition of inflammatory debris.
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2.07.017Introduction
Vernal keratoconjunctivitis (VKC) is an ocular allergy
disease that predominantly affects young males in their
first decade of life and subsides after puberty. This bilat-
eral, seasonal, and recurrent disease usually presents with
intense itching, photophobia, and copious mucoid
discharge. Clinical characteristics of VKC include giant
papillae on the upper tarsal conjunctiva or at the limbus,& Formosan Medical Association. All rights reserved.
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corneal scar that may result in severe visual impairment.1
VKC was classified into three categories: palpebral,
limbal, and mixed form.2 Shield ulcer with corneal plaque is
uncommon and is found only in 3.25% patients. However, it
is a serious vision-threatening complication that puts
patients at risk of occlusion amblyopia.3 In these cases,
secondary infection or perforation could also occur.2,4e6
Surgical debridement is necessary in cases with corneal
plaque unresponsive to conservative medical treatment.2
Amniotic membrane transplantation (AMT) has been used
widely to treat ocular surface disease in the past decade.7
Amniotic membrane has several functions including facili-
tation of epithelialization,8 inhibition of fibrosis,9 and
anti-inflammatory10 and antimicrobial11 effects. AMT has
successfully been applied in neurotrophic ulcers, persistent
epithelial defects, microbial keratitis, band keratopathy,
bullous keratopathy, following photorefractive keratec-
tomy, chemical injury, pterygium, and symblepharon.12
In this report, we will demonstrate the effects of
surgical management with AMT, describe the histopatho-
logic findings of the ulcers, and discuss their possible role in
VKC.
Case reports
Case 1
A 13-year-old boy had a history of atopic diseases including
asthma, dermatitis, and rhinitis. Because of severe symp-
toms of eye itching, tearing, and diffuse papillary hyper-
trophy on the upper palpebral conjunctiva, VKC was
diagnosed at the age of 7 years. Topical betamethasone and
cromolyn sodium in both eyes and oral cetirizine were
prescribed. Steroid-induced glaucoma was observed, and
topical betaxolol was used to control the intraocular
pressure.
Repeated episodes of grade 2 shield ulcer developed in
the left eye since March 2005. Intensive topical dexa-
methasone was given. Surgical debridement, superficial
keratectomy, and excimer laser phototherapeutic kera-
tectomy with bandage contact lens were performed four
times during June 2005 to January 2006 with partial effect.
However, a corneal plaque developed at the upper part in
March 2006 (Fig. 1). The best-corrected visual acuity (BCVA)
decreased to 0.05 in the left eye. Lamellar keratectomyFigure 1 Case 1. Photographs prior to operation. Corneal epithwith AMT was then performed on March 15, 2006. Complete
re-epithelialization was found within 1 week after surgery.
Another episode of shield ulcer occurred in the right eye
of the patient in December 2006. The BCVA was 0.05. He
had another surgery of lamellar keratectomy with AMT in
January 2007. Due to severe itching and tearing, the
amniotic membrane dislodged in postoperative 3 weeks
prior to complete re-epithelialization. The corneal plaque
at the nasal part was observed 3 months after the persis-
tent epithelial defect (Fig. 1). Repeated surgeries of
lamellar keratectomy with AMT were needed during
FebruaryeApril 2007. Complete re-epithelialization was
achieved 1 month after the last surgery. The postoperative
BCVA was 0.1 in the right eye and 0.2 in the left eye (Fig. 2).
Case 2
An 8-year-old boy presented with symptoms of eye itching
and photophobia for 1 year. Oral antihistamine and topical
drugs were given, but in vain. Bilateral shield ulcer had
persisted for 4 months when the boy first came to our
hospital on March 20, 2007. The BCVA was 0.7 in the right
eye and 0.2 in the left eye. Examination revealed corneal
plaques located at the lower part of the right eye and the
upper part of the left eye (Fig. 3). The patient was treated
with topical dexamethasone and oral levocetirizine. There
was no response to the medical treatment. Hence, lamellar
keratectomy in both eyes and AMT in the left eye were
performed on March 28, 2007. Shield ulcer healed after the
amniotic membrane was removed 6 weeks postoperatively.
The BCVA improved to 1.0 in the right eye and 0.4 in the left
eye (Fig. 3) 3 months after surgery.
Surgery
Surgeries were performed under general anesthesia. The
corneal plaque was excised with a No. 64 crescent surgical
blade. Lamellar keratectomy was performed to the depth
to which the plaque invaded. The plaque and the sur-
rounded superficial corneal stroma were removed in both
cases. No remarkable surgical plane between the plaque
and the Bowman’s layer was identified. The entire cornea,
including the area of denuded stromal bed, was then
covered with the amniotic membrane. The amniotic
membrane with stroma-side up and basement membrane-
side down was secured to the episclera around the limbuselial defect with white corneal plaque (arrows) in both eyes.
Figure 2 Case 1. Photographs after operation. Corneal opacity located at the central part of the cornea in both eyes.
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ferential sutures were used, and the knots were buried
followed by application of a therapeutic soft contact lens.
All the preoperative medications were continued in the
postoperative period.
Histopathologic and immunohistochemical
study
All the specimens taken during lamellar keratectomy were
fixed in formalin, embedded in paraffin, and sent for
histopathologic study. An immunohistochemical study was
carried out to confirm the presence and location of
eosinophil-derived major basic protein (MBP) on hematox-
ylineeosin sections. We performed procedures similar to
those mentioned earlier. The lymph node, which was filled
with eosinophils, derived from a patient with Kimura
disease served as a positive control. Von Kossa stain was
also performed to confirm whether the calcification existed
in the whitish plaque.
Microscopic examination of hematoxylineeosin-stained
sections revealed a thick layer of eosinophilic material
attached tomost surface of the Bowman’s layer in both cases
(Fig. 4, top). The laminated material tightly adhered to the
underlying Bowman’s layer. The epithelial cells were absent
in the area where the Bowman’s layer was coated with the
eosinophilic material. The residual epithelium showed mild
hyperkeratosis and parakeratosis. There was no inflamma-
tory infiltration inside or below the eosinophilic plaque.
Positive granular staining for eosinophil MBP was presented
by an immunohistochemical study in the sections.Figure 3 Case 2. (A) Photograph prior to operation. Large corneal
Corneal scar located in the central area.Discussion
VKC is an immune-mediated disorder of conjunctiva. The
inflammatory disease has a multifactorial pathogenesis
involving both Type I and Type IV hypersensitivity. Since
the mechanism is unclear, most studies indicate that
eosinophils, mast cells, lymphocytes, and a complex
network of interleukins and cell mediators play major roles
in the clinical presentation.13 In the study of Bonini et al,14
eosinophils were constantly detected in the epithelium
of conjunctival scraping (85%). In contrast, basophils,
neutrophils, and lymphocytes were observed rarely. They
concluded that activated eosinophils with their mediators
and adhesion molecules are the key factors in ocular
surface inflammation and tissue damage.
Shield ulcer with corneal plaque is rare but can result in
a severe visual development problem in children. Two
hypotheses regarding shield ulcer were proposed in the
literature. First is the mechanical hypothesis, according to
which shield ulcer is caused by the friction from giant
papillae on the upper tarsal conjunctiva and subsequent
recurrent corneal abrasion.1 This is why shield ulcer is more
frequently located in the superior cornea (63.5% vs. 10.6%
inferior) and is of palpebral type (85.4% vs. 2.4% limbal).2
Second is the toxin hypothesis, which emphasizes the
toxic effect of inflammatory mediators on the tear film.15
These cytotoxic compounds may inhibit wound healing of
shield ulcer and cause persistent corneal epithelial defects.
Cameron2 proposed a classification system for shield
ulcer based on the initial presentation. Patients having
ulcers with a transparent base (grade 1) had rapid re-plaque (arrows) in the left eye. (B) Photograph after operation.
Figure 4 (A) Case 1, hematoxylin and eosin stain (100). (B) Case 2, hematoxylin and eosin stain (400). (A and B, top) Dense
laminated layer of eosinophilic material (green arrows) adhered to Bowman’s layer (black arrowheads) in both cases. Asterisks
designate stroma. There is no residual epithelium under the thick eosinophilic layer. (A and B, bottom) Positive staining for
eosinophil major basic protein (brown stain) in the plaque adhered onto Bowman’s layer.
572 H.-Y. Lin et al.epithelialization under medical treatment alone. They had
mild corneal scarring and favorable visual outcome. When
opaque white or yellow deposits developed in part of the
clear base (grade 2), poor medical response with delayed
re-epithelialization usually presented at this stage.
Dramatic re-epithelialization was followed by a simple
surgical procedure. Two patients in our study had elevated
plaques (grade 3) above the level of the surrounding
epithelium. Worst visual prognosis in this group was caused
by significant retardation of epithelial healing, corneal
scarring, and high risk of concomitant bacterial keratitis. In
Cameron’s report, two out of 15 (13%) plaques recurred
after surgical debridement.
Corneal plaque (grade 3) usually presented after
a period of nonhealing epithelial defect. Immunochemical
evidence of eosinophil granule MBP was found in the
deposit.16 The cytotoxic effect of MBP has been disclosed in
human tissues.17 In animal studies, corneal epithelial
wound healing was inhibited by MBP.18 The rate of epithe-
lial cell migration during re-epithelialization was affected
by MBP in proportion to the concentration. A higher
concentration of MBP could nearly abort cell migration and
protein synthesis.16,18 Piled-up leading edge of epithelium
was also observed, especially in high-concentration group,
as a sign of poor wound healing. The abnormal findings
strengthened the cytotoxic theory of MBP deposit compli-
cated with prolonged shield ulcer.
Eosinophil granule MBP was identified in the ocular
surface, such as tear film and conjunctiva, of patients with
VKC.15,19 Electron microscopy showed superficial erosion of
the Bowman’s layer, with collagen fibril extending into the
corneal plaque.20 In our cases, histopathologic studies
confirmed that the Bowman’s layer was firmly attached to
the lamellar MBP in both patients with grade 3 shield ulcer,
which might be devoid of epithelium coverage.21
Based on the clinical presentation, histopathologic
findings of our cases, and previous studies,11,14 we suggest
that abundant MBP derived from tear and conjunctiva,
especially the giant papillae, initiates the pathogenesis of
shield ulcer. The interpapillary space of palpebral VKC can
serve as a reservoir of the cytotoxic material. As a high
concentration of the MBP accumulates on the ocularsurface, the punctate erosions advance to a more severe
injurydcoarse epithelial keratopathy. Since the deposit
hinders the migration of epithelial cells on the Bowman’s
layer and exerts cytotoxic effect on re-epithelialization,
a persistent corneal wound develops. Once the epithelial
defect persists for several weeks, the cytotoxic substances
may precipitate on the denuded Bowman’s layer and form
a thick plaque. The vicious circle contributes to the poor
wound healing in grade 3 shield ulcer with corneal plaque.
Management of corneal plaque in VKC should include
both removal and prevention of deposition from the cyto-
toxic protein. Although a mechanical factor might
contribute to the shield ulcer, papillectomy, which reduces
the friction and probably decreases a small amount of MBP
load, usually has limited effects on wound healing. Papillae
regrowth was observed in most patients.22 In our cases,
therapeutic soft contact lens had been prescribed to
protect corneal wound from friction, but in vain. Reduction
of mechanical trauma without inhibiting cytotoxic effects
was not enough.
Early surgical scraping or debridement of inflammatory
deposit was suggested by Cameron.2 In grade 2 ulcer, re-
epithelialization usually occurs within 1 week. However,
in grade 3 VKC plaques, firm adherence from corneal plaque
to the underlying Bowman’s layer was observed. Partial
resection of the Bowman’s membrane could not be avoided
as no surgical plane was detected between the two layers
on electron microscopy.20 Excimer laser phototherapeutic
keratectomy may help smoothen ocular surface and remove
residual inflammatory deposits.23
The amniotic membrane patch served as a basement
membrane that facilitates migration of epithelial cells,
promotes adhesion of basal cells, and prevents epithelial
apoptosis.8 AMT in combination with debridement had been
reported to be effective in treating shield ulcer.24 However,
in our case, early melting of the amniotic membrane was
significant in severe ulcer due to profound inflammation.
The exposure wound might lead to recurrence of cytotoxic
deposits in ulcer base postoperatively prior to complete
re-epithelialization. Instead of grafting, we covered the
denuded stroma after lamellar keratectomy using the
amniotic membrane as a therapeutic contact lens.
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tained, especially in Case 2. No recurrence of corneal pla-
que was noted in both cases in the following 2 years.
Successful results were also observed in a case study with
a relatively shorter duration of epithelial defects.25 We
believed that the advantages include sheltering the ulcer
base from deposition of cytotoxic protein and providing
various growth factors.
MBP, one of the several cationic proteins secreted from
activated eosinophils, plays an important role in the
mechanism of shield ulcer with corneal plaque. Whether
there is any other cytotoxic material within the plaque has
not been demonstrated. Besides, strong adhesion between
a corneal plaque and the underlying Bowman’s layer
observed in clinicopathological findings suggests close
interaction between MBP and collagen fibers.16 Further
studies may focus on the target therapy of eosinophil
cytotoxic proteins and the management of their tight
connection with corneal collagen fibers.
In conclusion, shield ulcer with corneal plaque is derived
from the vicious circle formed by cytotoxic protein and poor
re-epithelialization. Successful management of the compli-
cated VKC further confirmed the nature of the disease.
Lamellar keratectomy with AMT offers an effective manage-
ment by removing the cytotoxic plaques and protecting the
denuded stroma from deposition of inflammatory debris.2,24
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